Find Grants for Higher Education
Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-282
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Occupational Safety and Health Training Project Grants (T03)
Deadline: October 26, 2028
Opportunity Number: RFA-OH-25-003
Agency: Centers for Disease Control and Prevention - ERA
Open Date: November 22, 2024
Close Date: October 26, 2028
Status: Posted
CFDA Numbers: 93.262
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Deadline: November 19, 2026
Opportunity Number: PAR-25-226
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.242
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-290
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-291
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-148
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.396, 93.865, 93.866, 93.393, 93.395, 93.173, 93.394, 93.172, 93.273, 93.242, 93.279, 93.839, 93.867, 93.840, 93.837, 93.361, 93.233, 93.838, 93.399
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
Deadline: June 17, 2026
Opportunity Number: RFA-NS-25-016
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: June 17, 2026
Status: Posted
CFDA Numbers: 93.173, 93.866, 93.273, 93.853, 93.286, 93.279, 93.867, 93.242, 93.213, 93.865
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-274
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Deadline: May 4, 2026
Opportunity Number: PAR-25-106
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 4, 2026
Status: Posted
CFDA Numbers: 93.394, 93.395
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-268
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-267
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-287
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-286
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-235
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242, 93.879
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Deadline: May 7, 2027
Opportunity Number: PAR-26-001
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.307, 93.273, 93.399, 93.121, 93.279, 93.313
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Deadline: May 7, 2026
Opportunity Number: PAR-25-254
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.399
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Deadline: October 8, 2027
Opportunity Number: PAR-25-248
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: October 8, 2027
Status: Posted
CFDA Numbers: 93.393
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Deadline: November 18, 2027
Opportunity Number: RFA-DA-26-034
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 18, 2027
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Deadline: October 14, 2027
Opportunity Number: PAR-25-135
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: October 14, 2027
Status: Posted
CFDA Numbers: 93.398
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Deadline: November 19, 2026
Opportunity Number: PAR-25-052
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.853
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-112
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-113
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-243
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Deadline: November 16, 2027
Opportunity Number: PAR-25-244
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.393
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-038
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
